Machine Learning and Digital Biomarkers Can Detect Early Stages of Neurodegenerative Diseases
Open accessThe DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases (NDs) such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) are devastating conditions that can develop without noticeable symptoms, causing irreversible damage to neurons before any signs become clinically evident. NDs are a major cause of disability and mortality worldwide. Currently, there are no cures or treatments to halt their progression. Therefore, the development of early detection methods is urgently needed to delay neuronal loss as soon as possible. Despite advancements in Medtech, the early diagnosis of NDs remains a challenge at the intersection of medical, IT, and regulatory fields. Thus, this review explores “digital biomarkers” (tools designed for remote neurocognitive data collection and AI analysis) as a potential solution. The review summarizes that recent studies combining AI with digital biomarkers suggest the possibility of identifying pre-symptomatic indicators of NDs. For instance, research utilizing convolutional neural networks for eye tracking has achieved significant diagnostic accuracies. ROC-AUC scores reached up to 0.88, indicating high model performance in differentiating between PD patients and healthy controls. Similarly, advancements in facial expression analysis through tools have demonstrated significant potential in detecting emotional changes in ND patients, with some models reaching an accuracy of 0.89 and a precision of 0.85. This review follows a structured approach to article selection, starting with a comprehensive database search and culminating in a rigorous quality assessment and meaning for NDs of the different methods. The process is visualized in 10 tables with 54 parameters describing different approaches and their consequences for understanding various mechanisms in ND changes. However, these methods also face challenges related to data accuracy and privacy concerns. To address these issues, this review proposes strategies that emphasize the need for rigorous validation and rapid integration into clinical practice. Such integration could transform ND diagnostics, making early detection tools more cost-effective and globally accessible. In conclusion, this review underscores the urgent need to incorporate validated digital health tools into mainstream medical practice. This integration could indicate a new era in the early diagnosis of neurodegenerative diseases, potentially altering the trajectory of these conditions for millions worldwide. Thus, by highlighting specific and statistically significant findings, this review demonstrates the current progress in this field and the potential impact of these advancements on the global management of NDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Growing access to speech data through mobile platforms, telehealth, and ambient voice technology is accelerating progress in this domain.105,106”
From Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias (2026) · cites this paper as [106]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On computable numbers, with an application to the entscheidungsproblem
Turing, A. M. (1937) · Proceedings of the London Mathematical Society · doi:10.1112/plms/s2-42.1.230 · Cited by 8,283
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Pawlak, Z. (1991) · Springer eBooks · doi:10.1007/978-94-011-3534-4 · Cited by 3,040 · cited 1×
“Introduced by Pawlak (1982), the RST offers a framework for understanding how the brain processes complex visual information, despite the imprecise nature of concepts representing objects’ physical properties [114,115].”
BackgroundEye Tracking Methodology: Theory and Practice
Duchowski, A. T. (2003) · Springer eBooks · doi:10.1007/978-1-4471-3750-4 · Cited by 2,242
Openface 2.0: facial behavior analysis toolkit
Baltrusaitis, T., Zadeh, A., Lim, Y. C., & Morency, L.-P. (2018) · 2018 13th IEEE International Conference on Automatic Face & Gesture Recognition (FG 2018) · doi:10.1109/fg.2018.00019 · Cited by 1,861 · cited 1×
“Importantly, mature open-source projects like OpenFace provide state-of-the-art results for selected facial action unit (AU) recognition [54].”
BackgroundAlzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
Reitz, C., & Mayeux, R. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.024 · Cited by 1,181
The SAGE Encyclopedia of Communication Research Methods
Allen, M. (2017) · doi:10.4135/9781483381411 · Cited by 1,103
The Parkinson Pandemic—A Call to Action
Dorsey, E. R., & Bloem, B. R. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3299 · Cited by 1,091 · cited 1×
“This is due to a combination of factors, including an aging population, declining smoking rates, and increasing industrialization [11,12].”
BackgroundZadeh, L. A. (1999) · IEEE Transactions on Circuits and Systems I: Fundamental Theory and Applications · doi:10.1109/81.739259 · Cited by 1,039
Adult hippocampal neurogenesis and its role in Alzheimer’s disease
Mu, Y., & Gage, F. H. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-85 · Cited by 1,021 · cited 1×
“Changes in the hippocampus, including altered neurogenesis, are early events in AD and may worsen memory impairment [26].”
BackgroundThe chemical basis of morphogenesis
TURING, A. (1990) · Bulletin of Mathematical Biology · doi:10.1016/s0092-8240(05)80008-4 · Cited by 986
The current and projected economic burden of Parkinson's disease in the United States
Kowal, S. L., Dall, T. M., Chakrabarti, R., Storm, M. V., & Jain, A. (2013) · Movement Disorders · doi:10.1002/mds.25292 · Cited by 667 · cited 2×
“This is due to a combination of factors, including an aging population, declining smoking rates, and increasing industrialization [11,12].”
BackgroundTechnology in Parkinson’s disease: challenges and opportunities
Espay, A. J., Bonato, P., Nahab, F. B., Maetzler, W., Dean, J. M., Klucken, J., Eskofier, B. M., Merola, A., Horak, F., Lang, A. E., et al. (2016) · Movement Disorders · doi:10.1002/mds.26642 · Cited by 654 · cited 1×
“Moreover, Espay et al. (2016) discuss the challenges and opportunities in utilizing technology for PD diagnosis and treatment [108].”
BackgroundNaslund, J. A., Aschbrenner, K. A., Araya, R., Marsch, L. A., Unützer, J., Patel, V., & Bartels, S. J. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30096-2 · Cited by 638 · cited 1×
“Chinner (2018) and Naslund (2017) highlight how these tools, by leveraging widely available technology, become practical even in resource-limited settings and offer an affordable alternative to traditional diagnostic methods [101,102].”
BackgroundStrategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
Frisoni, G. B., Boccardi, M., Barkhof, F., Blennow, K., Cappa, S., Chiotis, K., Démonet, J.-F., Garibotto, V., Giannakopoulos, P., Gietl, A., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30159-x · Cited by 626 · cited 1×
“However, the validation of the clinical usefulness of these biomarkers is still incomplete, and further research is needed to standardize their readout and evaluate their performance in detecting early disease [18].”
BackgroundHippocampus and its involvement in Alzheimer’s disease: a review
Rao, Y. L., Ganaraja, B., Murlimanju, B. V., Joy, T., Krishnamurthy, A., & Agrawal, A. (2022) · 3 Biotech · doi:10.1007/s13205-022-03123-4 · Cited by 573 · cited 1×
“AD onset is primarily linked to changes in the hippocampus, which rapidly loses tissue and functional connectivity with other brain regions, leading to atrophy and cognitive impairment [25].”
BackgroundDigital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity
Kourtis, L. C., Regele, O. B., Wright, J. M., & Jones, G. B. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0084-2 · Cited by 476 · cited 1×
“This accuracy was further validated in subjects with MCI due to AD, corroborated by positive beta-amyloid and imaging biomarkers [81].”
The chemical basis of morphogenesis
Turing, A. M. (1990) · Bulletin of Mathematical Biology · doi:10.1007/bf02459572 · Cited by 434
Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders
DeKosky, S. T., & Marek, K. (2003) · Science · doi:10.1126/science.1090349 · Cited by 406 · cited 1×
“Furthermore, these tools might even help find these diseases before any symptoms show up, and this could lead to new ways to treat the diseases [68].”
BackgroundExploring EEG Features in Cross-Subject Emotion Recognition
Li, X., Song, D., Zhang, P., Zhang, Y., Hou, Y., & Hu, B. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00162 · Cited by 367 · cited 1×
“Li et al. (2018) examined the significance of 18 types of linear and non-linear EEG features in cross-subject emotion recognition, encompassing various channels, brain regions, rhythms, and feature types [63].”
BackgroundTorous, J., & Roberts, L. W. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0262 · Cited by 362 · cited 1×
“The issue regarding guidelines and transparency is highlighted by Torous (2017), who emphasizes the need for transparency and trust in the evaluation and use of these applications, given the concerns about their proliferation and the lack of established guidelines [104].”
BackgroundThe Epidemiology of Dementia Associated with Parkinson's Disease
Aarsland, D., & Kurz, M. W. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00369.x · Cited by 338 · cited 1×
“This disease is characterized mainly by motor but also by cognitive disorders [10].”
BackgroundEspay, A. J., Hausdorff, J. M., Sánchez‐Ferro, Á., Klucken, J., Merola, A., Bonato, P., Paul, S. S., Horak, F. B., Vizcarra, J. A., Mestre, T. A., et al. (2019) · Movement Disorders · doi:10.1002/mds.27671 · Cited by 321 · cited 1×
“As a solution, Espay et al. (2019) formed The International Parkinson and Movement Disorders Society Task Force on Technology, which aims to address these issues by promoting the development of open-source and open-hardware platforms for multichannel data capture [109].”
MethodChanges in Brain Function Occur Years before the Onset of Cognitive Impairment
Beason-Held, L. L., Goh, J. O., An, Y., Kraut, M. A., O'Brien, R. J., Ferrucci, L., & Resnick, S. M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1402-13.2013 · Cited by 293 · cited 1×
“Processes correlated with AD begin over 30 years, whereas cognitive changes begin over about 15–11 years, before the first AD symptoms [6,7].”
BackgroundThe Ageing Brain: Molecular and Cellular Basis of Neurodegeneration
Azam, S., Haque, M. E., Balakrishnan, R., Kim, I.-S., & Choi, D.-K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.683459 · Cited by 255 · cited 1×
“Aging is a significant risk factor for neurodegenerative diseases (NDs) such as Alzheimer’s (AD) and Parkinson’s (PD), despite advancements in technology that have improved our quality of life and longevity [1–3].”
BackgroundPiau, A., Wild, K., Mattek, N., & Kaye, J. (2019) · Journal of Medical Internet Research · doi:10.2196/12785 · Cited by 252 · cited 1×
“In mild cognitive impairment, AI and virtual reality can be used to create predictive models based on digital biomarkers, enabling early detection and interventions [69,70].”
MethodPrashanth, R., Dutta Roy, S., Mandal, P. K., & Ghosh, S. (2016) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2016.03.001 · Cited by 244 · cited 1×
“This method applies data mining techniques to attributes considered to be early symptoms of PD, such as cognitive disorders, rapid eye movements, sleep behavior disorders, and cerebrospinal fluid measurements [39].”
MethodBloem, B. R., Henderson, E. J., Dorsey, E. R., Okun, M. S., Okubadejo, N., Chan, P., Andrejack, J., Darweesh, S. K. L., & Munneke, M. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30064-8 · Cited by 242 · cited 1×
“As articulated by Bloem et al. (2020), the patient centricity of digital tools is imperative for sustained patient engagement [110].”
BackgroundManera, V., Petit, P.-D., Derreumaux, A., Orvieto, I., Romagnoli, M., Lyttle, G., David, R., & Robert, P. H. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00024 · Cited by 215 · cited 1×
“Similarly, another study focused on the Smart Aging Serious Game (SASG) demonstrated the effectiveness of digital platforms in cognitive health assessment [83,84].”
BackgroundCognitive assessment tools for mild cognitive impairment screening
Zhuang, L., Yang, Y., & Gao, J. (2021) · Journal of Neurology · doi:10.1007/s00415-019-09506-7 · Cited by 215 · cited 1×
“Therefore, the development of cognitive screening tools like the VST must prioritize UX design [87,88].”
MethodIbarretxe‐Bilbao, N., Junque, C., Tolosa, E., Marti, M., Valldeoriola, F., Bargallo, N., & Zarei, M. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06892.x · Cited by 200 · cited 1×
“In another study, the authors identified a correlation between impaired facial emotion recognition, detectable through online tools, and neuroanatomical changes that necessitate laboratory examinations [61].”
BackgroundPathak, N., Vimal, S. K., Tandon, I., Agrawal, L., Cao, H., & Bhattacharyya, S. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00800-w · Cited by 183 · cited 1×
“Despite the fact that Alzheimer’s and Parkinson’s are in the same cluster of disorders, they exhibit distinct biological characteristics [23].”
BackgroundTraditional and Digital Biomarkers: Two Worlds Apart?
Babrak, L. M., Menetski, J., Rebhan, M., Nisato, G., Zinggeler, M., Brasier, N., Baerenfaller, K., Brenzikofer, T., Baltzer, L., Vogler, C., et al. (2019) · Digital Biomarkers · doi:10.1159/000502000 · Cited by 181 · cited 2×
“…and digital biomarkers and points out the necessity for synchronization and unique feature definition claiming, therefore, that the unclear definition of digital biomarkers, population groups, and their intersection with traditional biomarkers hinders their discovery and validation [22].”
BackgroundCurrent Concepts of Neurodegenerative Mechanisms in Alzheimer’s Disease
Magalingam, K. B., Radhakrishnan, A., Ping, N. S., & Haleagrahara, N. (2018) · BioMed Research International · doi:10.1155/2018/3740461 · Cited by 178 · cited 1×
“Unfortunately, the complexity of the disease process, involving various contributing factors, presents a challenge in identifying effective remedies [4].”
BackgroundA cellular platform for the development of synthetic living machines
Blackiston, D., Lederer, E., Kriegman, S., Garnier, S., Bongard, J., & Levin, M. (2021) · Science Robotics · doi:10.1126/scirobotics.abf1571 · Cited by 178 · cited 1×
“Interestingly, this approach resonates with the research of Levin et al. (2021) who created the first living robots , known as xenobots [113].”
BackgroundNeural Correlates of Spatial Navigation Changes in Mild Cognitive Impairment and Alzheimer’s Disease
Vlček, K., & Laczó, J. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00089 · Cited by 167
The first frontier: digital biomarkers for neurodegenerative disorders
Dorsey, E. R., Papapetropoulos, S., Xiong, M., & Kieburtz, K. (2017) · Digital Biomarkers · doi:10.1159/000477383 · Cited by 162 · cited 1×
“Conversely, digital technologies, which provide objective, high-frequency data, are being considered as a solution to the current subjective measures of NDs [19].”
BackgroundAssociation Between Timed Up‐and‐Go and Memory, Executive Function, and Processing Speed
Donoghue, O. A., Horgan, F., Savva, G. M., Cronin, H., O’Regan, C., & Kenny, R. A. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04120.x · Cited by 160 · cited 1×
“Their analysis revealed that slower TUG performance is independently associated with poorer global cognition, executive function, memory, and slower processing speed [91].”
BackgroundApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease
Lane-Donovan, C., & Herz, J. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.12.001 · Cited by 157 · cited 1×
“Processes correlated with AD begin over 30 years, whereas cognitive changes begin over about 15–11 years, before the first AD symptoms [6,7].”
BackgroundStriate cortex increases contrast gain of macaque LGN neurons
PRZYBYSZEWSKI, A. W., GASKA, J. P., FOOTE, W., & POLLEN, D. A. (2000) · Visual Neuroscience · doi:10.1017/s0952523800174012 · Cited by 154 · cited 1×
“Importantly, this theory is further supported by In higher visual brain areas, the described processes utilize Granular Computing (GrC) to identify upper and lower approximations of the retinal image. geniculate nucleus (LGN) [118].”
MethodSelf-citationBiological Marker Candidates of Alzheimer's Disease in Blood, Plasma, and Serum
Schneider, P., Hampel, H., & Buerger, K. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00104.x · Cited by 152 · cited 1×
“Despite these challenges, the development of bioassays (sensitive biological detection tests) and the identification of biological markers in blood, plasma, and serum have shown promise in overcoming these limitations [17].”
BackgroundWebcam-based online eye-tracking for behavioral research
Yang, X., & Krajbich, I. M. (2021) · Judgment and Decision Making · doi:10.1017/s1930297500008512 · Cited by 152
Early-stage Alzheimer disease: getting trial-ready
Aisen, P. S., Jimenez-Maggiora, G. A., Rafii, M. S., Walter, S., & Raman, R. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00645-6 · Cited by 150 · cited 1×
“This hidden progression of the disease makes early detection a challenge in research, which can hinder the development of prevention strategies [29,30].”
BackgroundGold, M., Amatniek, J., Carrillo, M. C., Cedarbaum, J. M., Hendrix, J. A., Miller, B. B., Robillard, J. M., Rice, J. J., Soares, H., Tome, M. B., et al. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.04.003 · Cited by 143 · cited 1×
“They can help guide changes in how people live and decide who should join medical studies [65,67].”
BackgroundDeep learning approach to text analysis for human emotion detection from big data
Guo, J. (2022) · Journal of Intelligent Systems · doi:10.1515/jisys-2022-0001 · Cited by 141 · cited 1×
“Such an example is the study presented in “Deep learning approach to text analysis for human emotion detection from big data”, where the authors introduced a Deep Learning-Assisted Semantic Text Analysis (DLSTA) for identifying human emotions in text documents using big data [64].”
Li, R., Wang, X., Lawler, K., Garg, S., Bai, Q., & Alty, J. (2022) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2022.104030 · Cited by 137
Parkinson's disease and Alzheimer's disease as disorders of the isodendritic core.
Rossor, M. N. (1981) · BMJ · doi:10.1136/bmj.283.6306.1588 · Cited by 132 · cited 1×
“The complexity of NDs lies in a spectrum of disorders characterized by a primary loss of cells, leading to secondary cell loss in other brain regions [5].”
BackgroundZis, P., Erro, R., Walton, C. C., Sauerbier, A., & Chaudhuri, К. R. (2015) · npj Parkinson s Disease · doi:10.1038/npjparkd.2015.13 · Cited by 110 · cited 1×
“Importantly, symptoms can occur in the pre-motor phase of the disease and are not fully addressed by current treatments [32].”
BackgroundFord, E. M., Milne, R., & Curlewis, K. (2023) · Wiley Interdisciplinary Reviews Data Mining and Knowledge Discovery · doi:10.1002/widm.1492 · Cited by 96 · cited 1×
“As Ford, Milne, and Curlewis (2023) discuss, deploying digital biomarkers and AI at scale raises concerns regarding accuracy, bias, and equitable access [106].”
BackgroundClassification and staging of Parkinson's disease using video-based eye tracking
Brien, D. C., Riek, H. C., Yep, R., Huang, J. C. H., Coe, B. C., Areshenkoff, C. N., Grimes, D., Jog, M., Lang, A. E., Marras, C., et al. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105316 · Cited by 92
Early Detection of Mild Cognitive Impairment (MCI) in an At-Home Setting
Sabbagh, M. N., Boada, M., Soo Borson, B., Doraiswamy, P. M., Dubois, B., Ingram, J., Iwata, A., Porsteinsson, A. P., Possin, K. L., Rabinovici, G. D., et al. (2020) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2020.22 · Cited by 91 · cited 1×
“They might help slow down the diseases [65,66].”
BackgroundContreras-Somoza, L. M., Irazoki, E., Toribio-Guzmán, J. M., Díez, I. D. L. T., Diaz-Baquero, A. A., Parra−Vidales, E., Bartolomé, M. V. P., & Franco, M. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.636116 · Cited by 89 · cited 1×
“Therefore, the development of cognitive screening tools like the VST must prioritize UX design [87,88].”
MethodCavedoni, S., Chirico, A., Pedroli, E., Cipresso, P., & Riva, G. (2020) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2020.00245 · Cited by 85 · cited 1×
“In mild cognitive impairment, AI and virtual reality can be used to create predictive models based on digital biomarkers, enabling early detection and interventions [69,70].”
MethodDoroszkiewicz, J., Groblewska, M., & Mroczko, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094610 · Cited by 82 · cited 1×
“It has shown promise in detecting neuronal dysfunction in the presymptomatic stage of NDs [14].”
BackgroundCalcium, Bioenergetics, and Parkinson’s Disease
Zampese, E., & Surmeier, D. J. (2020) · Cells · doi:10.3390/cells9092045 · Cited by 79
Definitions of digital biomarkers: a systematic mapping of the biomedical literature
Macias Alonso, A. K., Hirt, J., Woelfle, T., Janiaud, P., & Hemkens, L. G. (2024) · BMJ Health & Care Informatics · doi:10.1136/bmjhci-2023-100914 · Cited by 73 · cited 1×
“Finally, and recently, Alonso et al. (2023) even concluded that there is no consensus about what this emerging term means [75].”
BackgroundEyelid Dysfunction in Neurodegenerative, Neurogenetic, and Neurometabolic Disease
Hamedani, A. G., & Gold, D. R. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00329 · Cited by 71 · cited 1×
“Eye movement disorders offer a window into early changes in brain computation, especially as they are affected early in neurodegenerative diseases [35].”
BackgroundAssunção, S. S., Sperling, R. A., Ritchie, C., Kerwin, D. R., Aisen, P. S., Lansdall, C., Atri, A., & Cummings, J. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-00984-y · Cited by 71 · cited 2×
“This hidden progression of the disease makes early detection a challenge in research, which can hinder the development of prevention strategies [29,30].”
BackgroundDementia medical screening using mobile applications: A systematic review with a new mapping model
Thabtah, F., Peebles, D., Retzler, J., & Hathurusingha, C. (2020) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2020.103573 · Cited by 69 · cited 1×
“As Thabtah (2020) noted, some of these apps employ advanced techniques like machine learning and AI to enhance diagnostic accuracy [100].”
BackgroundOrlosky, J., Itoh, Y., Ranchet, M., Kiyokawa, K., Morgan, J., & Devos, H. (2017) · IEEE Transactions on Visualization and Computer Graphics · doi:10.1109/tvcg.2017.2657018 · Cited by 67 · cited 1×
“For example, Orlosky et al. (2017) deliberate the need to conduct research in a laboratory environment [52].”
BackgroundGene expression parallels synaptic excitability and plasticity changes in Alzheimer’s disease
Saura, C. A., Parra-Damas, A., & Enriquez-Barreto, L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00318 · Cited by 65 · cited 1×
“These changes in the hippocampus and associated brain regions are associated with altered gene expression, synaptic excitability, and plasticity, which contribute to memory loss in AD [28].”
BackgroundDeep Learning Based Emotion Recognition and Visualization of Figural Representation
Lu, X. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.818833 · Cited by 65 · cited 1×
“Lu et al. (2022) investigated the recognition of emotions in speech and the graphic representation of expressions gathered during the learning process [62].”
BackgroundDigital biomarker‐based individualized prognosis for people at risk of dementia
Buegler, M., Harms, R. L., Balasa, M., Meier, I. B., Exarchos, T., Rai, L., Boyle, R., Tort, A., Kozori, M., Lazarou, E., et al. (2020) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12073 · Cited by 62 · cited 1×
“This high level of accuracy is significant as it showcases the potential of mobile-based applications in the pre-symptomatic detection of NDs. Altoida’s recognition by regulatory bodies like the FDA and CE further highlights its clinical relevance [82].”
BackgroundReview of automated emotion-based quantification of facial expression in Parkinson’s patients
Sonawane, B., & Sharma, P. (2020) · The Visual Computer · doi:10.1007/s00371-020-01859-9 · Cited by 56 · cited 1×
“A comprehensive review examined the role of computational analysis techniques in measuring emotional facial expressions in PD patients [60].”
BackgroundAging and Eye Tracking: in the Quest for Objective Biomarkers
Marandi, R. Z., & Gazerani, P. (2019) · Future Neurology · doi:10.2217/fnl-2019-0012 · Cited by 53 · cited 1×
“Additionally, when combined with facial expression analysis, eye tracking becomes even more powerful [36].”
BackgroundWebcam-Based Eye Movement Analysis Using CNN
Meng, C., & Zhao, X. (2017) · IEEE Access · doi:10.1109/access.2017.2754299 · Cited by 52 · cited 1×
“Meng et al. (2017) presented a paper where CNNs were employed in conjunction with webcams for an eye-tracking approach that relies on the detection of key eye features, including the inner and outer corners, the center of the upper and lower eyelids, and the center of the iris [44].”
MethodBogza, L.-M., Patry-Lebeau, C., Farmanova, E., Witteman, H. O., Elliott, J., Stolee, P., Hudon, C., & Giguere, A. M. C. (2020) · Journal of Medical Internet Research · doi:10.2196/17406 · Cited by 52 · cited 1×
“Hence, but not surprisingly, user-centered design and evaluation are crucial in clarifying and adjusting the level of detail in web-based decision aids for individuals with MCI [89].”
BackgroundThe Disease Modification Conundrum in Parkinson’s Disease: Failures and Hopes
Mari, Z. K., & Mestre, T. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.810860 · Cited by 51 · cited 2×
“The importance of those detectors, sensitive enough to catch invisible signs of the disease, is repeatedly underlined in the literature [20,33].”
BackgroundDigital technologies for the assessment of cognition: a clinical review
Chinner, A., Blane, J., Lancaster, C. L., Hinds, C., & Koychev, I. G. (2018) · Evidence-Based Mental Health · doi:10.1136/eb-2018-102890 · Cited by 50 · cited 1×
“Chinner (2018) and Naslund (2017) highlight how these tools, by leveraging widely available technology, become practical even in resource-limited settings and offer an affordable alternative to traditional diagnostic methods [101,102].”
BackgroundIs Reaction Time Slowing an Early Sign of Alzheimer’s Disease? A Meta-Analysis
Andriuta, D., Diouf, M., Roussel, M., & Godefroy, O. (2019) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000500348 · Cited by 50 · cited 2×
“%) than in the HC group [92].”
MethodInfluentialMobed, A., & Hasanzadeh, M. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.05.257 · Cited by 50 · cited 1×
“However, the use of analog biomarkers in Alzheimer’s Disease diagnosis has limitations, including the need for biological samples and hospitalization [16].”
BackgroundMachine Learning and Eye Movements Give Insights into Neurodegenerative Disease Mechanisms
Przybyszewski, A. W., Śledzianowski, A., Chudzik, A., Szlufik, S., & Koziorowski, D. (2023) · Italian National Conference on Sensors · doi:10.3390/s23042145 · Cited by 49 · cited 1×
“Moreover, eye tracking in Virtual Reality (VR) technology is being actively explored for remote diagnosis of neurodegenerative diseases [51].”
BackgroundSelf-citationZabel, C., Nguyen, H. P., Hin, S. C., Hartl, D., Mao, L., & Klose, J. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.08.008 · Cited by 47 · cited 1×
“Aging is a significant risk factor for neurodegenerative diseases (NDs) such as Alzheimer’s (AD) and Parkinson’s (PD), despite advancements in technology that have improved our quality of life and longevity [1–3].”
BackgroundParkinson’s disease in the older patient
Lewis, S. J. G., Gangadharan, S., & Padmakumar, C. P. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-4-376 · Cited by 46
Deep Neural Networks for Low-Cost Eye Tracking
Rakhmatulin, I., & Duchowski, A. T. (2020) · Procedia Computer Science · doi:10.1016/j.procs.2020.09.041 · Cited by 46 · cited 1×
“Finally, Rakhmatulin and Duchowski (2020) provide an in-depth analysis of contemporary techniques for webcam-based gaze tracking, offering practical implementations of popular methods [46].”
BackgroundDesigning ICTs for Users with Mild Cognitive Impairment: A Usability Study
Castilla, D., Suso-Ribera, C., Zaragoza, I., Garcia-Palacios, A., & Botella, C. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17145153 · Cited by 41 · cited 1×
“This is important because usability studies have shown that users with MCI require more time and help to complete tasks and that the speed of audio help can significantly impact performance [90].”
BackgroundIliadou, P., Paliokas, I., Zygouris, S., Lazarou, E., Votis, K., Tzovaras, D. K., & Tsolaki, M. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201300 · Cited by 41 · cited 1×
“It is possible to register elevated EEG rhythms in the MCI group when solving tasks in virtual reality, which therefore may be associated with an overall cognitive decline [85].”
BackgroundBurke, D., Linder, S. M., Hirsch, J. R., Dey, T., Kana, D., Ringenbach, S. D. R., Schindler, D., & Alberts, J. L. (2016) · Assessment · doi:10.1177/1073191116633752 · Cited by 39 · cited 1×
“That is supported by Burke (2017), who demonstrated that devices like the Apple iPad and iTouch can accurately measure reaction times [95].”
Digital Biomarker–Based Interventions: Systematic Review of Systematic Reviews
Motahari-Nezhad, H., Alabdulkarim, H. A., Fgaier, M., Abid, M. M., Péntek, M., Gulàcsi, L., & Zrubka, Z. (2022) · Journal of Medical Internet Research · doi:10.2196/41042 · Cited by 38 · cited 1×
“This critique follows Motahari-Nezhad (2022), who emphasizes the need for high-quality studies and the consideration of methodological criteria and evidence quality [73].”
BackgroundMammen, J. R., Speck, R. M., Stebbins, G. M., Müller, M. L. T. M., Yang, P. T., Campbell, M., Cosman, J., Crawford, J. E., Dam, T., Hellsten, J., et al. (2023) · Journal of Parkinson’s Disease · doi:10.3233/jpd-225122 · Cited by 38 · cited 2×
“The integration of clinical scales, imaging, biosamples, and digital tools is suggested as the most effective approach for characterizing and monitoring disease [33].”
BackgroundMethodValidating the Accuracy of Reaction Time Assessment on Computer-Based Tablet Devices
Schatz, P., Ybarra, V. T., & Leitner, D. S. (2015) · Assessment · doi:10.1177/1073191114566622 · Cited by 34 · cited 1×
“However, Schatz (2015) emphasized the need for careful validation and calibration of these digital tools, particularly tablet-based devices, to ensure accurate reaction time assessments [98].”
BackgroundcCOG: A web‐based cognitive test tool for detecting neurodegenerative disorders
Rhodius‐Meester, H. F. M., Paajanen, T. I., Koikkalainen, J. R., Mahdiani, S., Bruun, M., Baroni, M., Lemstra, A. W., Scheltens, P., Herukka, S., Pikkarainen, M., et al. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12083 · Cited by 33 · cited 1×
“…cognitive testing approach presented in “cCOG: A web-based cognitive test tool for detecting neurodegenerative disorders” explores the effectiveness of a web-based cognitive tool in detecting mild cognitive impairment and dementia for standardized screening in neurodegenerative disorders [103].”
MethodGielis, K., Abeele, M.-E. V., Verbert, K., Tournoy, J., Vos, M. D., & Abeele, V. V. (2021) · Digital Biomarkers · doi:10.1159/000514105 · Cited by 31 · cited 1×
“…when introduced properly, even the casual card game Klondike Solitaire may measure time-related values (like time spent on thinking of a move) that can be useful in distinguishing games played by older people with MCI from their healthy peers (AUC > 0.877), as presented by Gielis (2021) [99].”
BackgroundInfluentialHackett, K., & Giovannetti, T. (2022) · JMIR Aging · doi:10.2196/38130 · Cited by 29 · cited 1×
“Furthermore, an increasing array of Medtech tools are being developed to monitor daily routines and behaviors, capturing early cognitive changes indicative of NDs [72].”
BackgroundQuantitative Evaluation of Hypomimia in Parkinson’s Disease: A Face Tracking Approach
Pegolo, E., Volpe, D., Cucca, A., Ricciardi, L., & SAWACHA, Z. (2022) · Sensors · doi:10.3390/s22041358 · Cited by 28 · cited 1×
“Pegolo et al. (2022), addressing hypomimia in PD, aimed to create a quantitative index, termed the Face Mobility Index (FMI), utilizing a face tracking algorithm based on the Facial Action Coding System [58].”
MethodFrey, A.-L., Karran, M., Jiménez, R. C., Baxter, J., Adeogun, M., Bose, N., Chan, D., Crawford, J., Dagum, P., Everson, R., et al. (2019) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/u49z5 · Cited by 28 · cited 2×
“They might help slow down the diseases [65,66].”
BackgroundConvolutional Neural Network-Based Technique for Gaze Estimation on Mobile Devices
Akinyelu, A. A., & Blignaut, P. J. (2022) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2021.796825 · Cited by 27 · cited 1×
“Akinyelu et al. (2022) utilized the face component, gaze features were extracted from the eyes, and the shape and location of the eyes were encoded into the network through a 39-point facial landmark component and a Visual Geometry Group (VGG) convolutional neural network [43].”
MethodPreventing neurodegenerative disease
Al‐Chalabi, A. (2021) · Brain · doi:10.1093/brain/awab151 · Cited by 23 · cited 1×
“Hence, the best chance to fight NDs is to estimate the beginning period of the ND-related brain changes [13].”
BackgroundDigital phenotyping and the (data) shadow of Alzheimer's disease
Milne, R., Costa, A., & Brenman, N. F. (2022) · Big Data & Society · doi:10.1177/20539517211070748 · Cited by 23
Usability of the Virtual Supermarket Test for Older Adults with and without Cognitive Impairment
Zygouris, S., Segkouli, S., Triantafyllidis, A. K., Giakoumis, D., Tsolaki, M., Votis, K., & Tzovaras, D. K. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210064 · Cited by 23 · cited 2×
“Furthermore, there was a notable correlation between the SUS score and VST performance (r = − 0.496, p = 0.000), suggesting that better usability is associated with more accurate cognitive assessment [86].”
BackgroundMethodInfluentialThe Neurophysiological Bases of Cognitive Computation Using Rough Set Theory
Przybyszewski, A. W. (2008) · Lecture notes in computer science · doi:10.1007/978-3-540-89876-4_16 · Cited by 22 · cited 1×
“This suggests that concept representation based on similarities rather than symbols may be a more accurate model for how the brain works [116].”
BackgroundSelf-citationIsernia, S., Cabinio, M., Tella, S. D., Pazzi, S., Vannetti, F., Gerli, F., Mosca, I. E., Lombardi, G., Macchi, C., Sorbi, S., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210347 · Cited by 21 · cited 3×
“With a focus on mild cognitive impairment and vascular cognitive impairment (VCI), conditions associated with a heightened risk of developing dementia, the research aimed to validate SASG’s diagnostic capabilities [84].”
BackgroundPerformance Analysis of CNN Models for Mobile Device Eye Tracking with Edge Computing
Gunawardena, N., Ginige, J. A., Javadi, B., & Lui, G. Y. (2022) · Procedia Computer Science · doi:10.1016/j.procs.2022.09.288 · Cited by 19 · cited 1×
“They compared four modern lightweight CNN models (LeNet-5, AlexNet, MobileNet, and ShuffleNet) in search of optimal performance in real-time eye tracking based on video oculometry [45].”
BackgroundClassification of Alzheimer's using Deep-learning Methods on Webcam-based Gaze Data
Harisinghani, A., Sriram, H., Conati, C., Carenini, G., Field, T. S., Jang, H., & Murray, G. (2023) · Proceedings of the ACM on Human-Computer Interaction · doi:10.1145/3591126 · Cited by 19 · cited 1×
“A similar off-eye-tracker approach is presented by Harisinghani et al. (2023) [50].”
MethodRemote Eye Tracking Systems: Technologies and Applications
Narcizo, F. B., de Queiroz, J. E. R., & Gomes, H. M. (2013) · SIBGRAPI Conference on Graphics, Patterns and Images (SIBGRAPI) · doi:10.1109/sibgrapi-t.2013.8 · Cited by 17 · cited 1×
“However, eye-tracking has traditionally been considered an expensive research method due to the high cost of commercial eye tracking systems [42].”
MethodRai, L. A., Boyle, R. T., Brosnan, L., Rice, H., Farina, F. R., Tarnanas, I., & Whelan, R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32622-7_14 · Cited by 16 · cited 1×
“The Altoida model, based on app data, demonstrated high accuracy (AUC = 0.92) in predicting the transition from MCI to dementia [80].”
MethodInfluentialToward a Computing Model Dealing with Complex Phenomena: Interactive Granular Computing
Dutta, S., & Skowron, A. (2021) · Lecture notes in computer science · doi:10.1007/978-3-030-88081-1_15 · Cited by 16 · cited 1×
“Dutta and Skowron (2021) have used complex granules (c-granules) to model longitudinal disease development, finding that the RST provides the best estimations of disease progression [120].”
BackgroundBonnechère, B. (2022) · Games for Health Journal · doi:10.1089/g4h.2021.0144 · Cited by 16 · cited 1×
“Bonnech è re (2022) extended this work by using cognitive mobile games to assess the evolution of reaction times across different tasks [96].”
BackgroundPiendel, L. A., Vališ, M., & Hort, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1134096 · Cited by 16 · cited 1×
“These tools, including AI and remote sensing technologies, are promising avenues for early detection and monitoring of neurodegenerative diseases that can be deployed non-invasively and potentially at scale [20,21].”
BackgroundNonmotor Symptoms of Parkinson's Disease
Rektorová, I., Aarsland, D., Chaudhuri, К. R., & Strafella, A. P. (2011) · Parkinson s Disease · doi:10.4061/2011/351461 · Cited by 15
Predicting Visuo-Motor Diseases From Eye Tracking Data
Vodrahalli, K., Filipkowski, M., Chen, T., Zou, J., & Liao, Y. J. (2021) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789811250477_0023 · Cited by 13 · cited 1×
“In another research study by Vodrahalli et al. (2022), infrared oculography was used with visuo-motor tasks involving rapid reading of 40 single-digit numbers [40].”
MethodKlímová, B., Vališ, M., & Kuča, K. (2017) · Social Work in Health Care · doi:10.1080/00981389.2017.1316339 · Cited by 12 · cited 1×
“Those challenges were presented in several studies and projects that explored the use of digital technology in detecting and monitoring neurodegenerative diseases, though with varying degrees of success [78].”
BackgroundDigital biomarkers and digital phenotyping in mental health care and prevention
Andrea, A., Agulia, A., Serafini, G., & Amore, M. (2020) · European Journal of Public Health · doi:10.1093/eurpub/ckaa165.1080 · Cited by 12 · cited 1×
“This approach is notably transforming the way we understand and detect NDs, leveraging everyday technology to gather valuable health data [77].”
BackgroundDigital Biomarkers in Parkinson's Disease: Missing the Forest for the Trees?
Jha, A., Espay, A. J., & Lees, A. J. (2023) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13746 · Cited by 12 · cited 1×
“Furthermore, the main critique by Jha et al. (2023), termed the “Single Digital Biomarker Hypothesis,” revolves around the tendency of current digital measures to simplify the complexity of PD into a single severity score [107].”
BackgroundMonitoring of Cognitive Functioning by Measuring Reaction Times with Wearable Devices
Cinaz, B., Bert Arnrich, A., & Tröster, G. (2011) · International Conference on Pervasive Computing Technologies for Healthcare · doi:10.4108/icst.pervasivehealth.2011.246012 · Cited by 10 · cited 1×
“Already in 2011, Cinaz et al. explored wearable devices as tools for measuring reaction times, particularly in the context of everyday cognitive functioning, and concluded that they are feasible to measure changes in reaction times [94].”
BackgroundFacial Behaviour Analysis in Parkinson’s Disease
Almutiry, R., Couth, S., Poliakoff, E., Kotz, S. A., Silverdale, M., & Cootes, T. F. (2016) · Lecture notes in computer science · doi:10.1007/978-3-319-43775-0_30 · Cited by 10 · cited 1×
“The research introduces a method to assess facial expressivity for enhancing PD clinical evaluations [59].”
MethodDefinitions of digital biomarkers: a systematic mapping of the biomedical literaturePreprint
Alonso, A. K. M., Hirt, J., Woelfle, T., et al. (2023) · medRxiv · doi:10.1101/2023.09.01.23294897 · Cited by 9
Biomarkers in neurodegenerative disorders: translating research into clinical practice
Menéndez‐González, M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00281 · Cited by 8 · cited 1×
“These biomarkers, along with other laboratory and biochemical markers, are being explored for their potential in early diagnosis and disease progression assessment [15].”
BackgroundPrzybyszewski, A. W., Nowacki, J. P., Drabik, A., Szlufik, S., Habela, P., & Koziorowski, D. (2019) · Lecture notes in computer science · doi:10.1007/978-3-030-14802-7_51 · Cited by 7 · cited 1×
“= 0.33) groups [124].”
InfluentialSelf-citationPrzybyszewski, A. W., Chudzik, A., Szlufik, S., Habela, P., & Koziorowski, D. (2020) · Fundamenta Informaticae · doi:10.3233/fi-2020-1969 · Cited by 7 · cited 1×
“A further example is a study by Przybyszewski et al. (2020) analyzing patients under different treatments, which achieved varying degrees of accuracy, suggesting the potential to discover universal rules for PD progression [122].”
BackgroundSelf-citationAdvancing the science of digital biomarkers
Sobolev, M., Gullapalli, B. T., & Rahman, T. (2021) · doi:10.1145/3469266.3473711 · Cited by 7 · cited 1×
“As well, Sobolev (2021) highlights the potential of digital biomarkers in predicting and influencing health conditions but also underscores the need for technological integration and the challenges in this area [74].”
BackgroundNon-motor Symptoms in Parkinson’s Disease
Uc, E. Y., Tippin, J., Chou, K. L., Erickson, B. A., Doerschug, K. C., & Fletcher, D. M. J. (2011) · touchREVIEWS in Neurology · doi:10.17925/usn.2011.07.02.113 · Cited by 7
Digital phenotyping and personality disorders: A necessary relationship in the digital age
Carvalho, L. D. F., & Pianowski, G. (2019) · Psicologia - Teoria e Prática · doi:10.5935/1980-6906/psicologia.v21n2p122-133 · Cited by 6 · cited 1×
“That statement was further supported by de Francisco Carvalho (2019), who pointed out the necessity of clear ethical guidelines on how information can and should be used [105].”
BackgroundDönmez, G. (2013) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000071 · Cited by 5
Parkinson’s disease development prediction by c-granule computing compared to different AI methods
Przybyszewski, A. W., & Śledzianowski, A. (2020) · Journal of Information and Telecommunication · doi:10.1080/24751839.2020.1749410 · Cited by 5 · cited 1×
“Other AI methods gave similar results but only when looking for the disease progression without or with medication separately, indicating their limitations in looking for longitudinal PD progressions [121].”
ResultSelf-citationTheory of Mind Helps to Predict Neurodegenerative Processes in Parkinson’s Disease
Przybyszewski, A. W. (2021) · Lecture notes in computer science · doi:10.1007/978-3-030-77967-2_45 · Cited by 5 · cited 2×
“While it was found that the accuracy of prediction increased with disease progression, it is noted that divergent sets of granules characteristic of different parts of the brain might degenerate in different ways with disease progression [117].”
BackgroundSelf-citationFace emotional responses correlate with chaotic dynamics of eye movements
Śledzianowski, A., Urbanowicz, K., Glac, W., Słota, R., Wojtowicz, M., Nowak, M., & Przybyszewski, A. W. (2021) · Procedia Computer Science · doi:10.1016/j.procs.2021.09.059 · Cited by 5 · cited 1×
“Using this tool, ´Sledzianowski et al. (2021) studied facial emotions (FEs) through the muscle activity model (FACS) and chaos parameters in EMs [56].”
MethodSelf-citationPrzybyszewski, A. W., & the BIOCARD Study Team* (2022) · Lecture notes in computer science · doi:10.1007/978-3-031-08757-8_14 · Cited by 5 · cited 1×
“These findings highlight the capacity of AI methods to detect subtle cognitive changes that might indicate a pre-dementia stage [126].”
BackgroundSelf-citationBelan, A. F. R., Pais, M. V., Camargo, M. V. Z. D. A., Sant’Ana, L. C. F. G., Radanovic, M., & Forlenza, O. V. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230250 · Cited by 5 · cited 1×
“Belan et al. (2023) investigated the effectiveness of an eye-tracking-assisted visual inference language task in differentiating individuals with mild cognitive impairment (MCI) or Alzheimer’s Disease dementia from cognitively unimpaired older adults [41].”
BackgroundIGrC: Cognitive and Motor Changes During Symptoms Development in Parkinson’s Disease Patients
Przybyszewski, A. W., Nowacki, J. P., Drabik, A., Szlufik, S., & Koziorowski, D. (2020) · Lecture notes in computer science · doi:10.1007/978-3-030-42058-1_46 · Cited by 4 · cited 3×
“…able to identify rules from the BMTW1 data (patients receiving only medical treatment during their first visit) that allowed them to predict UPDRS scores for BMTW2 and BMTW3 with accuracies of 0.765 (0.7 without Beck test of depression result) and 0.8 (0.7 without Beck result), respectively [123].”
BackgroundInfluentialSelf-citationPrzybyszewski, A. W., Bojakowska, K., Nowacki, J. P., Drabik, A., & BIOCARD Study Team (2022) · Lecture notes in computer science · doi:10.1007/978-3-031-21743-2_11 · Cited by 4 · cited 1×
“The study’s findings suggest that AI methods can predict patterns in cognitive attributes of normal subjects that might indicate their pre-dementia stage, something that may not be visible to neuropsychologists [125].”
BackgroundSelf-citationLi, R., Wang, X., Lawler, K., Garg, S., Bai, Q., & Alty, J. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2104.14073 · Cited by 3 · cited 1×
“Moreover, AI shows the potential to assist with the detection of early-stage dementia, offering cost-effective and objective methods [71].”
BackgroundALTOIDA‐iADL for the diagnosis of Mild Cognitive Impairment and early Alzheimer's disease
Tort‐Merino, A., Tarnanas, I., Bügler, M., Harms, R., Fernández‐Villullas, G., Juncà‐Parella, J., Bosch, B., Lladó, A., Sánchez‐Valle, R., & Balasa, M. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.057982 · Cited by 3 · cited 1×
“One notable project in this domain is the Altoida initiative, which focuses on identifying digital biomarkers for mild cognitive impairment [79].”
BackgroundPredicting Visuo-Motor Diseases From Eye Tracking Data.
Vodrahalli, K., Filipkowski, M., Chen, T., et al. (2022) · PubMed · Cited by 3
Jutten, R. J., Rentz, D. M., Amariglio, R. E., Properzi, M. J., Maruff, P. T., Johnson, K. A., Sperling, R. A., & Papp, K. V. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.066578 · Cited by 3 · cited 1×
“They found that greater IIV-RT, especially in complex RT tasks, was associated with steeper cognitive decline in individuals with elevated AD biomarkers [97].”
BackgroundMulti-granular Computing Can Predict Prodromal Alzheimer’s Disease Indications in Normal Subjects
Przybyszewski, A. W. (2023) · Lecture notes in computer science · doi:10.1007/978-3-031-36024-4_22 · Cited by 3
Self-citationChudzik, A., Drabik, A., & Przybyszewski, A. W. (2023) · Lecture notes in computer science · doi:10.1007/978-981-99-5837-5_20 · Cited by 3 · cited 2×
“This finding is further supported by our recent study (2023) that involved collecting cognitive and behavioral data from PD patients and healthy controls [93].”
ResultInfluentialSelf-citationPupil and eye tracking measures as a tool for detection and intervention in neurodegeneration
O’Callaghan, C., Hezemans, F. H., Ye, R., Orlando, I., Passamonti, L., & Rowe, J. B. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.065889 · Cited by 2 · cited 1×
“O’Callaghan et al. (2022) focus on using pupil and oculomotor measures as biomarkers to detect changes in the locus coeruleus (LC) [53].”
BackgroundNovel Machine Learning Pipeline for Real-Time Oculometry
Śledzianowski, A., Nowacki, J. P., Sitarz, K., & Przybyszewski, A. W. (2023) · Communications in computer and information science · doi:10.1007/978-3-031-42430-4_41 · Cited by 2 · cited 1×
“´Sledzianowski et al. (2023) experimented with disconnecting the software from the hardware capabilities to compensate for the lack of professional equipment in the patient’s household [48,49].”
BackgroundSelf-citationDetecting True and Declarative Facial Emotions by Changes in Nonlinear Dynamics of Eye Movements
Śledzianowski, A., Nowacki, J. P., Przybyszewski, A. W., & Urbanowicz, K. (2022) · Lecture notes in computer science · doi:10.1007/978-3-031-21743-2_9 · Cited by 1 · cited 1×
“Interestingly, further validation was conducted using the Affectiva-MIT Facial Expression Dataset (AM-FED) which included both human and algorithmic classifications [57].”
MethodSelf-citationUniversal Machine-Learning Processing Pattern for Computing in the Video-Oculography
Śledzianowski, A., Nowacki, J. P., Sitarz, K., & Przybyszewski, A. W. (2023) · Lecture notes in computer science · doi:10.1007/978-3-031-36024-4_15 · Cited by 1 · cited 1×
“´Sledzianowski et al. (2023) experimented with disconnecting the software from the hardware capabilities to compensate for the lack of professional equipment in the patient’s household [48,49].”
BackgroundSelf-citation
Research works printed but not linked: 3
- Bejani, 2023, Detection of Parkinson’s Disease by Analysis of Smooth Pursuit Eye Movements and Machine Learning, Mov. Disord., 37, S184
- Rai, L., Boyle, R., Brosnan, L., Rice, H., Farina, F., and Tarnanas, I. (2020). GeNeDis 2018: Computational Biology and Bioinformatics, Springer.
- Pawlak, 1982, Rough sets, Int. J. Parallel Program., 11, 341
Cited by
Kale, M., Wankhede, N., Pawar, R., Ballal, S., Kumawat, R., Goswami, M., Khalid, M., Taksande, B., Upaganlawar, A., Umekar, M., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102497 · Cited by 183
Dangi, R. R., Sharma, A., & Vageriya, V. (2024) · Public Health Nursing · doi:10.1111/phn.13500 · Cited by 125
“This tailored approach helps optimize therapeutic efficacy and minimize adverse effects, enhancing overall patient management (Bi et al. 2021; Chudzik, Śledzianowski, and Przybyszewski 2024; Vrahatis et al. 2023).”
Ezzdine, L. B., Dhahbi, W., Dergaa, I., Ceylan, H. İ., Guelmami, N., Saad, H. B., Chamari, K., Ștefănică, V., & Omri, A. E. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1502417 · Cited by 119
“This section explores how these technologies are revolutionizing the development of personalized physical and cognitive rehabilitation programs for individuals with neurodegenerative diseases (Chudzik et al., 2024; Dergaa and Chamari, 2024).”
Noh, M., Kwon, H. S., Kwon, M., Nahm, M., Jin, H. K., Bae, J., & Kim, S. H. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00867-4 · Cited by 97
“Moreover, predictive models that integrate clinical biomarkers, neuroimaging, and genomic risk profiles from AD, PD, and ALS cohorts further refine translational pipelines [401–403].”
Yu, J., Zhou, R., Liu, S., Zheng, J., Yan, H., Su, S., Chai, N., Segal, E., Jiang, C., Guo, K., et al. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c02619 · Cited by 66
Metadata
- Authors
- Chudzik, A., Śledzianowski, A., & Przybyszewski, A. W.
- Affiliations
- Polish-Japanese Academy of Information Technology (PL)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Przybyszewski, Andrzej W.
- Venue
- Sensors
- Publisher
- MDPI AG
- Published
- 2024-02-29
- Volume
- 24
- Issue
- 5
- Pages
- 1572
- ISSN
- 1424-8220 (ISSN-L)
- PMC
- PMC10934426
- OpenAlex
- W4392285688
- Cited by
- 122
- References
- 131
- Citations by year
- 2026: 42 · 2025: 63 · 2024: 17
- FWCI
- 9.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Sensors (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Life Sciences › Neuroscience › Cognitive Neuroscience › EEG and Brain-Computer Interfaces
- Keywords
- neurodegenerative diseases, early diagnosis, digital biomarkers, Alzheimer's disease, Parkinson's disease, eye tracking, facial expression analysis, convolutional neural networks, presymptomatic detection, data privacy, clinical validation
- MeSH terms
- Machine Learning, Alzheimer Disease, Humans, Parkinson Disease, Biomarkers, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.